MRC1 and neoplasm: Analysis of tumor infiltrates lymphocytes (TILs) in dual therapy showed that TG100‐115 reversed immune suppression by reducing the ratio of CD206+ M2 macrophages, and improved CD8+ T cell numbers in residual and distant subcutaneous tumors, as well as orthotopic tumors (Figure S8A–C, Supporting Information, Figure 6D–F).